Annual Report

The report describes a strong FY22 performance for the company, with revenue from operations rising 67.89% year-on-year to ₹11,941.81 million and sales reaching 19.27 million pairs. It highlights healthcare-focused CSR initiatives responding to COVID-19, including vaccination camps, patient transfers and home assistance. The company also reports that a 1MW solar PV panel at its Ganaur plant became operational in January 2022. The report further documents the company's revised consolidated financial statements following the merger scheme.